What's the outlook for LYRA's 2025 Q1 EPS?

Lyra Therapeutics (LYRA) is forecasted to report an EPS of -$0.15 for the fiscal quarter ending March 31, 2025 (Q1 2025), based on the latest estimates: This outlook suggests that Lyra Therapeutics is expected to continue facing challenges, as indicated by the negative EPS projection. The company's financial performance is closely monitored, and any deviation from the estimated EPS can provide insights into the company's operational efficiency and market conditions.